Loading…
Lobbying Spend
—
Filings
8
Firms Hired
1
Active Period
2013–2014
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Compounding Clarity Act of 2013
2014 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54); H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.
Client expense: — · Firm income: $60,000
Matched citations: H.R.3089
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
2014 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Issues related to FY2015 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations and H.R.4800/S.2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015.
Client expense: — · Firm income: $60,000
Matched citations: S.2389
Continuing Appropriations Resolution, 2015
2014 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Issues related to FY2015 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, H.R.4800/S.2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015 and H.J.Res.124, Continuing Appropriations Resolution, 2015.
Client expense: — · Firm income: $60,000
Matched citations: H.J.Res.124
Compounding Clarity Act of 2013
2014 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54); H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.
Client expense: — · Firm income: $60,000
Matched citations: H.R.3089
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
2014 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Issues related to FY2015 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, H.R.4800/S.2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015 and H.J.Res.124, Continuing Appropriations Resolution, 2015.
Client expense: — · Firm income: $60,000
Matched citations: S.2389
Compounding Clarity Act of 2013
2014 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54); H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.
Client expense: — · Firm income: $60,000
Matched citations: H.R.3089
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
2014 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Issues related to FY2015 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations and H.R.4800/S.2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015.
Client expense: — · Firm income: $60,000
Matched citations: S.2389
Compounding Clarity Act of 2013
2014 · first_quarter · Firm: CROSSROADS STRATEGIES, LLC
Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54); H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.
Client expense: — · Firm income: $60,000
Matched citations: H.R.3089
Safeguarding America's Pharmaceuticals Act of 2013
2013 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.959, Pharmaceutical Quality, Security, and Accountability Act; H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1919
Compounding Clarity Act of 2013
2013 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.959, Pharmaceutical Quality, Security, and Accountability Act; H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.
Client expense: — · Firm income: $60,000
Matched citations: H.R.3089
Pharmaceutical Quality, Security, and Accountability Act
2013 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.959, Pharmaceutical Quality, Security, and Accountability Act; H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.
Client expense: — · Firm income: $60,000
Matched citations: S.959
Safeguarding America's Pharmaceuticals Act of 2013
2013 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.959, Pharmaceutical Quality, Security, and Accountability Act; H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1919
Compounding Clarity Act of 2013
2013 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.959, Pharmaceutical Quality, Security, and Accountability Act; H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.
Client expense: — · Firm income: $50,000
Matched citations: H.R.3089
Pharmaceutical Quality, Security, and Accountability Act
2013 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.959, Pharmaceutical Quality, Security, and Accountability Act; H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.
Client expense: — · Firm income: $50,000
Matched citations: S.959
Safeguarding America's Pharmaceuticals Act of 2013
2013 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.959, Pharmaceutical Quality, Security, and Accountability Act and H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013; FDA related issues-specifically pharmacy compounding.
Client expense: — · Firm income: —
Matched citations: H.R.1919
Pharmaceutical Quality, Security, and Accountability Act
2013 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.959, Pharmaceutical Quality, Security, and Accountability Act and H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013; FDA related issues-specifically pharmacy compounding.
Client expense: — · Firm income: —
Matched citations: S.959
Safeguarding America's Pharmaceuticals Act of 2013
2013 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.959, Pharmaceutical Quality, Security, and Accountability Act and H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013; FDA related issues-specifically pharmacy compounding.
Client expense: — · Firm income: —
Matched citations: H.R.1919
Pharmaceutical Quality, Security, and Accountability Act
2013 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.959, Pharmaceutical Quality, Security, and Accountability Act and H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013; FDA related issues-specifically pharmacy compounding.
Client expense: — · Firm income: —
Matched citations: S.959
Source: Senate LDA